The converstations part on the new version is getting some traffic. You should go elsewhere now, it looks like yahoo is going to keep it fubar with some going to the new version, and some coming here.
EVERY biotech stock I've watched over the years went down just before news was expected. Even when FDA did approve a drug, the stock did the same thing. I've never understood why.
Maybe short term traders were riding the uptick for fast profits, and don't want to take a chance on the trials, so they take their fast profit to the next short term.
Or, since volume is getting lower, shorts are driving it down so they can cover, or someone is driving it down so they can get more.
The one sure answer is, manipulation. It is frustrating. Especially considerin the company could do a PR saying the preliminary results are very encouraging and help us out.
Probably Class III. Trials will take 1-3 years.